Related Experiment Video
Updated: Aug 11, 2026

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Stress lysis in childhood leukemia
1Division of Clinical Pharmacology & Therapeutics and Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. adamsonp@mail.med.upenn.edu
Pediatric Blood & Cancer
|February 4, 2006
Summary
A significant drop in white blood cell count (WBC) is common in children with acute lymphoblastic leukemia (ALL) before treatment. This decrease is linked to stress-induced corticosteroid release, not medication.
Area of Science:
- Pediatric Oncology
- Hematology
Background:
- Children with acute lymphoblastic leukemia (ALL) often show a reduced white blood cell (WBC) count before chemotherapy.
- This phenomenon is frequently misattributed to allopurinol and hydration therapies.
Purpose of the Study:
- To investigate the cause of pre-chemotherapy WBC count decrease in newly diagnosed ALL patients.
- To determine if allopurinol or other interventions are responsible for the observed WBC drop.
Main Methods:
- Retrospective review of medical records for 20 children with newly diagnosed ALL.
- Analysis of WBC counts in the interval between referral evaluation and hospital admission, prior to allopurinol administration.
Main Results:
- 80% of patients exhibited a decrease in WBC count before chemotherapy.
- The median WBC decrease was 14,000/mm(3) within 24 hours.
- The observed decrease was statistically significant (P = 0.002).
Conclusions:
- The pre-chemotherapy WBC decrease in ALL is likely due to rapid lysis of leukemic cells.
- Stress-induced release of endogenous corticosteroids is the probable mechanism driving this phenomenon.
Related Concept Videos
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
